Integrating Factor Analysis and a Transgenic Mouse Model to Reveal a Peripheral Blood Predictor of Breast Tumors

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Labreche, Heather G ^a,b   Nevins, Joseph R ^a,b   Huang, Erich ^a,c,d  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d SAGE BIONETWORKS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; MYC PROTEIN; TRANSCRIPTOME; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER PATIENT; COHORT ANALYSIS; CONTROLLED STUDY; FACTORIAL ANALYSIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKOCYTE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; ONCOGENE MYC; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOLID TUMOR; STATISTICAL ANALYSIS; TRANSCRIPTOMICS; TRANSGENIC MOUSE; VALIDATION PROCESS; ADULT; AGED; ANIMAL; AREA UNDER THE CURVE; BLOOD; BREAST TUMOR; GENETICS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL;

ANIMALIA; MUS MUSCULUS;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; AREA UNDER CURVE; BREAST NEOPLASMS; COHORT STUDIES; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MICE; MICE, TRANSGENIC; MIDDLE AGED; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS C-MYC; ROC CURVE; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 79960562799     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-61     Document Type: Article

References (42)

1. Gene expression profiling of peripheral blood cells for early detection of breast cancer. Aaroe J, Lindahl T, Dumeaux V, Saebo S, Tobin D, Hagen N, Skaane P, Lonneborg A, Sharma P, Borresen-Dale AL, Breast Cancer Res 2010 12 7 10.1186/bcr2472 20078854
2. Novel blood-based, five-gene biomarker set for the detection of colorectal cancer. Han M, Liew CT, Zhang HW, Chao S, Zheng R, Yip KT, Song ZY, Li HM, Geng XP, Zhu LX, et al. Clin Cancer Res 2008 14 455 460 10.1158/1078-0432.CCR-07-1801 18203981 (Pubitemid 351226113)
3. Novel blood biomarkers of human urinary bladder cancer. Osman I, Bajorin DF, Sun TT, Zhong H, Douglas D, Scattergood J, Zheng R, Han M, Marshall KW, Liew CC, Clin Cancer Res 2006 12 3374 3380 10.1158/1078-0432.CCR-05-2081 16740760
4. Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. Sharma P, Sahni NS, Tibshirani R, Skaane P, Urdal P, Berghagen H, Jensen M, Kristiansen L, Moen C, Zaka A, et al. Breast Cancer Res 2005 7 634 644 10.1186/bcr1203 16168108
5. Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Showe MK, Vachani A, Kossenkov AV, Yousef M, Nichols C, Nikonova EV, Chang C, Kucharczuk J, Tran B, Wakeam E, et al. Cancer Res 2009 69 9202 9210 10.1158/0008-5472.CAN-09-1378 19951989
6. Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma. Twine NC, Stover JA, Marshall B, Dukart G, Hidalgo M, Stadler W, Logan T, Dutcher J, Hudes G, Dorner AJ, et al. Cancer Res 2003 63 6069 6075 14522937 (Pubitemid 37187512)
7. Microarray analysis reveals differences in gene expression of circulating CD8(+) T cells in melanoma patients and healthy donors. Xu T, Shu CT, Purdom E, Dang D, Ilsley D, Guo Y, Weber J, Holmes SP, Lee PP, Cancer Res 2004 64 3661 3667 10.1158/0008-5472.CAN-03-3396 15150126 (Pubitemid 38657946)
8. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, et al. Nature 2006 439 353 357 10.1038/nature04296 16273092 (Pubitemid 43128862)
9. Gene expression predictors of breast cancer outcomes. Huang E, Cheng SH, Dressman H, Pittman J, Tsou MH, Horng CF, Bild A, Iversen ES, Liao M, Chen CM, et al. Lancet 2003 361 1590 1596 10.1016/S0140-6736(03)13308-9 12747878 (Pubitemid 36578995)
10. Gene expression phenotypic models that predict the activity of oncogenic pathways. Huang E, Ishida S, Pittman J, Dressman H, Bild A, Kloos M, D'Amico M, Pestell RG, West M, Nevins JR, Nat Genet 2003 34 226 230 10.1038/ng1167 12754511 (Pubitemid 36666937)
11. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. Kamangar F, Dores GM, Anderson WF, J Clin Oncol 2006 24 2137 2150 10.1200/JCO.2005.05.2308 16682732 (Pubitemid 46655601)
12. SEER Cancer Statistics Review, 1975-2007. http://seer.cancer.gov/csr/ 1975-2008/index.html
13. Breast cancer tumor growth estimated through mammography screening data. Weedon-Fekjaer H, Lindqvist BH, Vatten LJ, Aalen OO, Tretli S, Breast Cancer Res 2008 10 41 10.1186/bcr2092 18466608
14. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. Porter PL, El-Bastawissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA, Cousens L, White D, Taplin S, White E, J Natl Cancer Inst 1999 91 2020 2028 10.1093/jnci/91.23.2020 10580027
15. Screening for breast cancer. Elmore JG, Armstrong K, Lehman CD, Fletcher SW, JAMA 2005 293 1245 1256 10.1001/jama.293.10.1245 15755947 (Pubitemid 40327910)
16. Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V, JAMA 1996 276 39 43 10.1001/jama.276.1.39 8667537 (Pubitemid 26231054)
17. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Kolb TM, Lichy J, Newhouse JH, Radiology 2002 225 165 175 10.1148/radiol.2251011667 12355001
18. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Rosenberg RD, Hunt WC, Williamson MR, Gilliland FD, Wiest PW, Kelsey CA, Key CR, Linver MN, Radiology 1998 209 511 518 9807581 (Pubitemid 28503121)
19. Assessing women at high risk of breast cancer: a review of risk assessment models. Amir E, Freedman OC, Seruga B, Evans DG, J Natl Cancer Inst 2010 102 680 691 10.1093/jnci/djq088 20427433
20. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, Cutrara MR, DeBoer G, Yaffe MJ, Messner SJ, et al. JAMA 2004 292 1317 1325 10.1001/jama.292.11.1317 15367553 (Pubitemid 39223222)
21. Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential. Andrechek ER, Cardiff RD, Chang JT, Gatza ML, Acharya CR, Potti A, Nevins JR, Proc Natl Acad Sci USA 2009 106 16387 16392 10.1073/pnas.0901250106 19805309
22. Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Leder A, Pattengale PK, Kuo A, Stewart TA, Leder P, Cell 1986 45 485 495 10.1016/0092-8674(86)90280-1 3011271 (Pubitemid 16014971)
23. Affymetrix NetAffx. http://www.affymetrix.com/analysis/index.affx
24. A bayesian analysis strategy for cross-study translation of gene expression biomarkers. Lucas J, Carvalho C, West M, Stat Appl Genet Mol Biol 2009 8 rticle 11 19222378
25. High-dimensional sparse factor modelling-Applicaitons in gene expression genomics. Carvalho CM, Lucas JE, Wang Q, Chang J, Nevins JR, West M, Journal of the American Statistical Association 2008 103 1438 1456 10.1198/ 016214508000000869 21218139
26. Shotgun stochastic search for "Large p" regression. Hans C, Journal of the American Statistical Association 2007 102 507 516 10.1198/016214507000000121
27. Bayesian Model Averaging: A Tutorial. Hoeting JA, Statistical Science 1999 14 382 417 10.1214/ss/1009212519
28. QUADRA. http://quadra.genome.duke.edu/mouse-2-human-mammary-tumor-pbmc- project
29. NCBI Gene Expression Omnibus. http://www.ncbi.nlm.nih.gov/geo/query/acc. cgi?acc = GSE27567
30. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Shi L, Campbell G, Jones WD, Campagne F, Wen Z, Walker SJ, Su Z, Chu TM, Goodsaid FM, Pusztai L, et al. Nat Biotechnol 2010 28 827 838 10.1038/nbt.1665 20676074
31. GATHER. http://gather.genome.duke.edu/
32. GATHER: a systems approach to interpreting genomic signatures. Chang JT, Nevins JR, Bioinformatics 2006 22 2926 2933 10.1093/bioinformatics/btl483 17000751 (Pubitemid 44811565)
33. GSEA-P: a desktop application for Gene Set Enrichment Analysis. Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP, Bioinformatics 2007 23 3251 3253 10.1093/bioinformatics/btm369 17644558 (Pubitemid 350187532)
34. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP, Proc Natl Acad Sci USA 2005 102 15545 15550 10.1073/pnas.0506580102 16199517 (Pubitemid 41528093)
35. Gene Set Enrichment Analysis. http://www.broadinstitute.org/gsea/msigdb/ annotate.jsp
36. Git. http://www.git-scm.org
37. Gitorious. http://www.gitorious.com
38. Blood genomics in human stroke. Baird AE, Stroke 2007 38 694 698 10.1161/01.STR.0000250431.99687.7b 17261718 (Pubitemid 46184244)
39. Gene expression in peripheral blood differs after cardioembolic compared with large-vessel atherosclerotic stroke: biomarkers for the etiology of ischemic stroke. Xu H, Journal of Cerebral Blood Flow and Metabolism 2008 28 1320 1328 10.1038/jcbfm.2008.22 18382470 (Pubitemid 351896646)
40. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, Pascual V, J Exp Med 2003 197 711 723 10.1084/jem.20021553 12642603 (Pubitemid 36350866)
41. Peripheral blood gene expression profiling in rheumatoid arthritis. Batliwalla FM, Baechler EC, Xiao X, Li W, Balasubramanian S, Khalili H, Damle A, Ortmann WA, Perrone A, Kantor AB, et al. Genes Immun 2005 6 388 397 10.1038/sj.gene.6364209 15973463 (Pubitemid 43090514)
42. Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Zaas AK, Chen M, Varkey J, Veldman T, Hero AO, Lucas J, Huang Y, Turner R, Gilbert A, Lambkin-Williams R, et al. Cell Host Microbe 2009 6 207 217 10.1016/j.chom.2009.07.006 19664979